Serum high-sensitivity c-reactive protein and heat shock protein 27 antibody titers in patients with stroke and 6-month prognosis

Mahmoud Reza Azarpazhooh, Naser Mobarra, Syyed Mohammad Reza Parizadeh, Shima Tavallaie, Mahsa Bagheri, Amir Ali Rahsepar, Majid Ghayour-Mobarhan*, Amirhossein Sahebkar, Gordon A.A. Ferns

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Serum heat shock protein 27 immunoglobulin G (IgG) antibody titers (anti-HSP27) and high-sensitivity C-reactive protein (hsCRP) concentrations were measured in samples from 168 patients in the first 24 hours after the onset of stroke and 80 age-and sex-matched control participants. In patients with stroke, median serum anti-HSP27 titer was significantly higher than that of the control group (0.18 [0.14-0.28] vs 0.08 [0.04-0.12], P <.001). Median serum hsCRP concentration was also significantly higher in patients compared with the control group (11.43 [8.07-13.53] vs 3.23 [1.66-6.24], P <.001). Serum anti-HSP27 and hsCRP concentrations did not differ significantly among patients with different stroke types. Neither serum anti-HSP27 nor hsCRP levels predicted 6-month prognosis in the patients with stroke. We conclude that serum anti-HSP27 titers and hsCRP concentrations are elevated in patients with stroke but do not distinguish between stroke types or predict 6-month prognosis.

Original languageEnglish (US)
Pages (from-to)607-612
Number of pages6
JournalAngiology
Volume61
Issue number6
DOIs
StatePublished - Aug 2010

Keywords

  • antibody
  • heat shock protein 27
  • high sensitive C-reactive protein
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Serum high-sensitivity c-reactive protein and heat shock protein 27 antibody titers in patients with stroke and 6-month prognosis'. Together they form a unique fingerprint.

Cite this